Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease
Alcohol Research: Current Reviews · 2021 · 41 (1)
DOI: 10.35946/arcr.v41.1.12 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alcohol Research: Current Reviews, 2021. Verfasst von Keungmo Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Liver Research, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, …. Hauptthemen laut MEDLINE: Cannabinoids, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Liver Research, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
- Biomedical Research Center, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
Zitieren
APA
Yang, K., Choi, S. E., & Jeong, W. I. (2021). Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease. Alcohol Research: Current Reviews, 41(1). https://doi.org/10.35946/arcr.v41.1.12
Vancouver
Yang K, Choi SE, Jeong WI. Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease. Alcohol Research: Current Reviews. 2021;41(1). doi:10.35946/arcr.v41.1.12
BibTeX
@article{Yang2021,
author = {Yang, Keungmo and Choi, Sung Eun and Jeong, Won-Il},
title = {Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease},
journal = {Alcohol Research: Current Reviews},
year = {2021},
volume = {41},
number = {1},
doi = {10.35946/arcr.v41.1.12}
}
EUVIMED